乳糖置于水,Saturated Solution,乳糖体系中,用 水 作为反应溶剂,化学反应生成 乳糖 参考文献:Process For The Treatment Of Particles For Use In Pharmaceutical Formulations 标题:Process For The Treatment Of Particles For Use In Pharmaceutical Formulations 摘要:一种适用于制药配方的粒子表面处理过程,包括在温度控制的环境中准备所述粒子所组成的物质的饱和溶液;将待处理的粒子悬浮在该饱和溶液中;将温度调整到预定水平,朝着该物质溶解度增加的方向;并收获经过处理的粒子.
专利号:US-9034844-B2 优先权日:2009-04-06 标 题 :6′-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides 发明人:TAMERLANI GIANCARLO; LOMBARDI ILARIA; BARTALUCCI DEBORA; DANESI ANDREA; SALSINI LIANA; MANONI MARCO; CIPOLLETTI GIOVANNI 权利人:TAMERLANI GIANCARLO; LOMBARDI ILARIA; BARTALUCCI DEBORA; DANESI ANDREA; SALSINI LIANA; MANONI MARCO; CIPOLLETTI GIOVANNI; INALCO SPA 摘要:The present invention relates to a process of synthesis of α-sialyl oligosaccharides and in particular of 6′-sialyllactose and its salts comprising a step of coupling by Koenigs-Knorr reaction under conditions that allow its use on an industrial scale.
专利号:US-12264143-B2 优先权日:2020-12-17 标 题:Synthesis of cannabinoids and cannabinoid precursors, and related compounds, formulations, and methods of use 发明人:SAMMIS GLENN M; ROGGEN MARKUS 权利人:NALU BIO INC 摘要:Methods are provided for the synthesis of cannabinoids, including cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabidiolic acid (CBDA), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabidivarin (CBDV), cannabidibutol (CBD-C4), dihydrocannabidiol (DCBD), tetrahydrocannabivarin (THCV), analogs thereof, and precursors to the foregoing. One method employs phloroglucinol or a phloroglucinol analog as a starting material. The syntheses are stereospecific, efficient, selective, and cost-effective, with little or no potential for generation of THC ((−)-trans-Δ9-tetrahydro-cannabinol) or any other psychoactive side product. Telescoped syntheses are also provided, as are new cannabinoids, pharmaceutical formulations, and methods of use.
专利号:WO-2004075874-A1 优先权日:2003-02-28 标题 :Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides 发明人:MENEKSE OKTAY 权利人:ANBICS PATENTS LICENCES AG; MENEKSE OKTAY 摘要:Macrolides, in particular azalides such as azithromycin, are suited for the treatment or prevention of acute or chronic P. aeruginosa infections of the airways by inhalaÂtion. The mechanism of action is the inhibition of the quoÂrum sensing of P. aeruginosa, in particular the impediment of the las and rhl quorum sensing systems synthesis and the impediment of the synthesis of the autoinducers N-[3-oxodoÂ1o decanoyl]-L-homoserine lactone and N-butyrylhomoserine lacÂtone. This allows for inhalation treatments of P. aerugi-nosa infections at non-inhibiting concentrations of the macrolide.
专利号:US-12043612-B2 优先权日:2020-05-09 标 题 :Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same 发明人:ALLAN LAURA E N; CHEN CHUNGPIN HERMAN; DONG HANQING; GROSSO JOHN A; HASKELL III ROYAL J; LLOYD RHYS; REECE HAYLEY 权利人:ARVINAS OPERATIONS INC 摘要:The present disclosure relates to ultra-pure forms, polymorphs, amorphous forms, and formulations of N-[(1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-({4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl]piperazin-1-yl}methyl)piperidin-1-yl]pyridazine-3-carboxamide, referred to herein as Compound A:The present disclosure also relates methods of manufacturing and purifying the same, as well as intermediates useful in the synthesis of Compound A. The ultra-pure forms, polymorphs, amorphous forms, and formulations of Compound A can be used as therapeutic agents for the treatment of various diseases and conditions such as cancer.
专利号:US-2024279698-A1 优先权日:2021-08-05 标 题 :Specific alpha-1,2-fucosyltransferase for the biocatalytic synthesis of 2'-fucosyllactose 发明人:MARTIN JULIA; BORNHÖVD CARSTEN 权利人:WACKER CHEMIE AG 摘要:An enzyme that it is a fusion protein. The enzyme includes an N-terminal domain of at least amino acids 1-129 of SEQ ID No. 7 or an amino acid sequence at least 80% identical thereto and that includes at least amino acids 155-286 of SEQ ID No. 5 or an amino acid sequence at least 80% identical thereto as a C-terminal domain and has fucosyltransferase activity. The N-terminal domain and the C-terminal domain being derived from two different fucosyltransferases.
专利号:US-2025049791-A1 优先权日:2023-08-03 标题:Synthesis of MEK7 Inhibitors and methods of Use Thereof 发明人:SCHEIDT KARL A; KIM DALTON ROBERT; ORR MEGHAN JO 权利人:UNIV NORTHWESTERN 摘要:Disclosed herein are 4-phenoxypyrimidine compounds and derivatives thereof for use as inhibitors of mitogen-activated protein kinase 7 (MEK7). The disclosed compounds and pharmaceutical compositions thereof may be used in methods for treating a disease or disorder associated with MEK7 activity, including cell proliferative diseases and disorders associated with MEK7 activity, such as cancer.
[参考文献]: Johannes Gursch, Et Al. Continuous Processing Of Active Pharmaceutical Ingredients Suspensions Via Dynamic Cross-Flow Filtration. J Pharm Sci. 2015 Oct;104(10):3481-9. [参考文献]: Sha Liu, Et Al. Formulation Of A Novel Fixed Dose Combination Of Salmeterol Xinafoate And Mometasone Furoate For Inhaled Drug Delivery. Eur J Pharm Biopharm. 2015 Oct:96:132-42.
合成参考文献
参考文献:10.1007/s11095-005-8926-9 摘要:Hussain A, Majumder QH, Ahsan F. Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides. Pharm Res. 2006 Jan;23(1):138–47. doi: 10.1007/s11095-005-8926-9.